Therefore, through the effect of inflammatory cytokines on lipid metabolism or by favouring a better control of HCV replication [211], IL28B favourable variants protect from the development of steatosis [232], and possibly from the steatosis-associated fibrosis progression and increased risk of HCC [230, 233]. This evidence concerns the gene IFNL3 and steatosis.